Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2250264
Reference Type
Journal Article
Title
Hypertensive urgency induced by an interaction of mirtazapine and clonidine
Author(s)
Abo-Zena, RA; Bobek, MB; Dweik, RA
Year
2000
Is Peer Reviewed?
1
Journal
Pharmacotherapy
ISSN:
0277-0008
EISSN:
1875-9114
Report Number
IPA/00/1200111
Volume
VOL 20 ISS 4 2000
Issue
REF 7
Page Numbers
476-478
Language
eng
Abstract
IPA COPYRIGHT: ASHP The case of a 20-yr-old man with hypertension whose blood pressure had been controlled with metoprolol, losartan, and clonidine and who was treated for hypertensive urgency 2 wk after starting mirtazapine for the treatment of depression is presented. After starting mirtazapine, the patient's blood pressure rose, and the dosage of losartan was increased. Since improved blood pressure control was not achieved, losartan was stopped and minoxidil was started. The patient's regimen at the time of presentation to the emergency department with hypertensive urgency included 0.1 mg of clonidine twice daily, 100 mg of metoprolol twice daily, 2.5 mg of minoxidil twice daily, and 15 mg of mirtazapine daily. He received treatment with intravenous injections of nitroglycerin, labetalol, and nitroprusside and emergency dialysis. On hospital day 2, it was discovered that the patient had been prescribed mirtazapine just 2 wk earlier. Because of a potential drug interaction between clonidine and mirtazapine, the latter agent was discontinued. Discharge therapy with controlled blood pressure consisted of 5 mg of minoxidil twice daily, 0.1 mg of clonidine twice daily, and 100 mg of metoprolol twice daily. The patient did not have any subsequent episodes of hypertensive urgency.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity